Company Monitoring Page for Novartis

latest headlines for company on cafepharma

Novartis stacks up more data for lucrative Cosentyx expansion
Fierce Pharma
Thu, 10/1/15 - 02:08 pm
Tags:
Novartis, Cosentyx, psoriasis
Xoma enters exclusive license agreement with Novartis
Marketwatch
Thu, 10/1/15 - 09:40 am
Tags:
Xoma, Novartis, cancer, antibodies
Novartis CEO: Here's How We'll Get Cheap Medicine To Poor Countries
Forbes
Wed, 09/30/15 - 09:42 am
Tags:
Novartis, Joe Jimenez, Pharma CEOs, developing countries
Bristol's Opdivo boosts kidney cancer survival beyond two years
Yahoo/Reuters
Sat, 09/26/15 - 09:54 am
Tags:
Bristol-Myers Squibb, Opdivo, kidney cancer, Novartis, Afinitor
Novartis brings heart, cancer meds to low-income countries for $1 per month
Fierce Pharma
Fri, 09/25/15 - 09:45 am
Tags:
Novartis, emerging markets
AbbVie Not Worried About Humira Biosimilars
Bidness, ETC
Mon, 09/21/15 - 10:54 am
Tags:
AbbVie, Humira, biosimilars, Gilead, Pfizer, Novartis, Amgen
Watch out, Afinitor. Bristol's 'breakthrough' Opdivo is coming for you
Fierce Pharma Marketing
Fri, 09/18/15 - 09:14 pm
Tags:
Bristol-Myers Squibb, Afinitor, Opdivo, Novartis, kidney cancer
An update on first-ever US biosim Zarxio 2 weeks after its debut
BioPharma Dive
Fri, 09/18/15 - 11:42 am
Tags:
Novartis, Sandoz, Zarxio, bioimilars, Amgen, Neupogen
Novartis will weather the EM market storm: CEO
CNBC
Fri, 09/18/15 - 10:49 am
Tags:
Novartis, Joe Jimenez, emerging markets
Pharma Deal-Making: In The Pink Of Health
Seeking Alpha
Wed, 09/16/15 - 10:26 am
Tags:
M&A, Baxalta, GSK, JNJ, Eli Lilly, Novartis, Perrigo, Shire
Faster track to 'megablockbuster'? Novartis' Entresto already soaring on social media
Fierce Pharma Marketing
Wed, 09/16/15 - 10:21 am
Tags:
Novartis, social media, Entresto
Novartis priced Entresto on par with results, new cost watchdog says
Fierce Pharma
Mon, 09/14/15 - 06:02 pm
Tags:
Novartis, Entresto, drug pricing, heart failure
Why is Novartis' Copaxone copy lagging? It's all about coverage, analyst explains
Fierce Pharma
Fri, 09/11/15 - 05:53 pm
Tags:
Novartis, Copaxone, MS, multiple sclerosis, biosimilars, Teva, Glatopa
Novartis CEO says diabetics' contact lens tests to start in 2016 -paper
Yahoo/Reuters
Sat, 09/5/15 - 11:13 am
Tags:
Novartis, Joe Jimenez, diabetes, contact lens, Google
Sandoz: Zarxio marketing to be similar to a branded-drug launch
Fierce Pharma Marketing
Thu, 09/3/15 - 06:46 pm
Tags:
Sandoz, Zarxio, biosimilars, Novartis, drug launches, Amgen, Neupogen
The Next Blockbusters Could Be Balms For Aging Eyes
Investors.com
Thu, 09/3/15 - 09:10 am
Tags:
age-related macular degeneration, Bayer, Regeneron, Ophthotech, Allergan, Novartis, Applied Genetic Technologies, Avalanche Biotechnologies, Roche, Lucentis, Eylea
Novartis launches first U.S. 'biosimilar' drug at 15 pct discount
Yahoo/Reuters
Thu, 09/3/15 - 08:45 am
Tags:
Novartis, biosimilars, Amgen, Neupogen, Zarxio, Sandoz
Novartis team tracks remissions of 4-plus years in a pioneering CAR-T study
Fierce Biotech
Thu, 09/3/15 - 08:40 am
Tags:
Novartis, CAR-T, CTL019, CLL, chronic lymphocytic leukemia
Amgen cannot stop imminent sale of Neupogen copycat: US appeals court
Yahoo/Reuters
Wed, 09/2/15 - 12:37 pm
Tags:
Amgen, Neupogen, biosimilars, Zarxio, Novartis, Sandoz
Novartis to Work With Amgen on Alzheimer’s and Migraine Drugs
Bloomberg
Wed, 09/2/15 - 10:18 am
Tags:
Novartis, Amgen, migraines, Alzheimer's disease, R&D, CNP520, AMG 334

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.